Skip to main content
Clinical Trials/NCT04783363
NCT04783363
Completed
Not Applicable

Study Comparing Satisfaction of Hospitalized Patients Receiving Invasive Care for Cancer Treatment, With Snoezelen Session Versus Standard Care (SNOEZELEN)

Institut de cancérologie Strasbourg Europe1 site in 1 country60 target enrollmentApril 12, 2021
ConditionsCancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer
Sponsor
Institut de cancérologie Strasbourg Europe
Enrollment
60
Locations
1
Primary Endpoint
Patient satisfaction regarding their perception of care quality (with or without Snoezelen session) at Visit 2
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This is a monocentric, comparative, open-label, randomized, crossover study enrolling patients hospitalized in Strasbourg Europe Cancerology Institute, receiving repeated invasive care for cancer treatment.

The purpose of this study is to compare the satisfaction of patients, regarding their perception of care, with or without Snoezelen session.

Detailed Description

Patients will followed during two visits for a repeated invasive care. They will be randomized to two groups in a 1:1 ratio. Crossover plan and arms are described as follow: Arm A : Visit 1 with Snoezelen session before invasive care and Visit 2 without Snoezelen session before invasive care (standard care) Arm B : Visit 1 without Snoezelen session before invasive care (standard care) and Visit 2 with Snoezelen session before invasive care

Registry
clinicaltrials.gov
Start Date
April 12, 2021
End Date
September 18, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Institut de cancérologie Strasbourg Europe
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients treated for cancer and hospitalized for invasive care
  • Two programmed hospitalization for repeated care
  • Patients receiving one of the following invasive care: Huber needle application (transfusion, parenteral nutrition), complex wound dressing, intrathecal chemotherapy, ascites fluid or pleural puncture
  • Patients must be ≥ 18 years old
  • Performance Status ≤ 3
  • Absence of psychiatric disorder impairing follow-up
  • Ability to speak, understand, write and read French
  • Signed informed consent from the patient
  • Affiliation to social security system

Exclusion Criteria

  • Patients presenting infectious symptoms requiring isolation
  • Patients \< 18 years old or patients ≥ 18 years old under supervision
  • Patients placed under judicial protection or guardianship
  • Women that are pregnant or breast-feeding

Outcomes

Primary Outcomes

Patient satisfaction regarding their perception of care quality (with or without Snoezelen session) at Visit 2

Time Frame: immediately after invasive care at Visit 2

Evaluation using a modified Visual Analog Scales, Oberts, 1984

Patient satisfaction regarding their perception of care quality (with or without Snoezelen session) at Visit 1

Time Frame: immediately after invasive care at Visit 1

Evaluation using a modified Visual Analog Scales, Oberts, 1984

Secondary Outcomes

  • Change in patient perceived pain, with or without Snoezelen session(At admission (i.e. before Snoezelen session, if applicable) and immediately after invasive care at Visit n°1; At admission (i.e. before Snoezelen session, if applicable) and immediately after invasive care at Visit n°2)
  • Comparing relationship between patient and caregiver, with or without Snoezelen session(immediately after invasive care at Visit 1 ; immediately after invasive care at Visit 2)
  • Change in patient perceived anxiety, with or without Snoezelen session(At admission (i.e. before Snoezelen session, if applicable) and immediately after invasive care at Visit n°1; At admission (i.e. before Snoezelen session, if applicable) and immediately after invasive care at Visit n°2)

Study Sites (1)

Loading locations...

Similar Trials